Aatru Medical has developed NPSIMS, a patented negative pressure wound therapy device that utilizes a solid-state oxygen management system to deliver consistent negative pressure for up to seven days. This technology effectively reduces surgical site infections and complications associated with surgical incisions, enhancing patient outcomes and streamlining clinical workflows.
Funding
$3.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Surgical site infections and complications, such as dehiscence, can negatively impact patient outcomes and increase healthcare costs. Traditional methods of surgical incision management may not adequately address factors that impede wound healing, particularly in patients with comorbidities.
Solution
Aatru Medical's NPSIMS (Negative Pressure Surgical Incision Management System) offers an innovative approach to surgical incision management by utilizing a solid-state oxygen management system to deliver consistent negative pressure wound therapy (NPWT) for up to seven days. This patented technology creates a closed environment that removes exudate, reduces edema and hematoma/seroma formation, and immobilizes wound edges, promoting faster and more effective healing. The device's unique mechanism of action, based on the Ideal Gas Law, requires no moving parts, batteries, or manual pressure adjustments, simplifying application and minimizing the risk of over-pressure. NPSIMS is designed for ease of use, patient comfort, and cost-effectiveness, offering a comprehensive solution for surgical incision management.
Target Audience
The primary target audience includes surgeons across various specialties (abdominal, cardiothoracic, colorectal, obstetric, orthopedic, pediatric, plastic/breast, trauma, vascular) and clinicians managing surgical incisions, particularly in patients with risk factors such as high BMI, diabetes, cardiovascular disease, or compromised immune systems.
Features
- Solid-state oxygen management system maintains consistent negative pressure (-80 mmHg +/- 20 mmHg) for up to 7 days.
- Patented mechanism of action with no moving parts, batteries, or pressure settings.
- Unique silicone gasket ensures a reliable vacuum seal.
- Defaults to an advanced wound dressing if pressure is lost.
- Super-absorbent pad locks in fluid and allows visual assessment of exudate.
- Simple visual indicators guide and alert on performance.
- Lightweight, compact, and contoured design for patient comfort and discreet wear.
- Pre-assembled for quick and easy application.